| 1 |
2025 |
Anna Di Spirito, Sahar Balkhi, Veronica Vivona, Lorenzo Mortara. Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies, Exploration of Targeted Anti-tumor Therapy. 2025; 6: 1002304.
https://doi.org/10.37349/etat.2025.1002304 |
| 2 |
2023 |
Natasa Kustrimovic, Raffaella Bombelli, Denisa Baci, Lorenzo Mortara. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment, International Journal of Molecular Sciences. 2023; 24: 1511.
https://doi.org/10.3390/ijms24021511 |
| 3 |
2024 |
Margarita Zvirble, Zilvinas Survila, Paulius Bosas, Neringa Dobrovolskiene, Agata Mlynska, Gintaras Zaleskis, Jurgita Jursenaite, Dainius Characiejus, Vita Pasukoniene. Prognostic significance of soluble PD-L1 in prostate cancer, Frontiers in Immunology. 2024; 15: 1401097.
https://doi.org/10.3389/fimmu.2024.1401097 |
| 4 |
2025 |
Akram Hoseinzadeh, Seyed-Alireza Esmaeili, Reza Sahebi, Anahita Madani Melak, Mahmoud Mahmoudi, Maliheh Hasannia, Rasoul Baharlou. Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights, Stem Cell Research & Therapy. 2025; 16: 33.
https://doi.org/10.1186/s13287-025-04158-z |
| 5 |
2025 |
Duo Zhang, Yu Heng, Qiu-yan Jin, Di Tang, Xiao-ke Zhu, Li-ming Lu, Chun-ping Wu, Lei Tao. Prognostic significance of cytotoxic-T-lymphocytes to immunosuppressive lymphocytes ratio (CIL) in laryngeal squamous cell carcinoma, Cancer Immunology, Immunotherapy. 2025; 74: 157.
https://doi.org/10.1007/s00262-025-04008-0 |
| 6 |
2023 |
Feixiang Yang, Jiawei Li, Qintao Ge, Yuchen Zhang, Meng Zhang, Jun Zhou, Haitao Wang, Juan Du, Shenglin Gao, Chaozhao Liang, Jialin Meng. Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer, Biochemical Pharmacology. 2023; 214: 115669115669.
https://doi.org/10.1016/j.bcp.2023.115669 |
| 7 |
2025 |
Ngan Nguyen, Ian C. Henrich. Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function through Shared and Distinct Pathways, Molecular Cancer Research. 2025; 23: 155.
https://doi.org/10.1158/1541-7786.MCR-24-0299 |
| 8 |
2023 |
O. A. Korovin, A. V. Alyasova, Kh. M. Arioua, D. V. Novikov, N. V. Krasnogorova, V. V. Novikov. Analysis of the IL-10 mRNA level in the peripheral blood of patients with cancer and benign prostatic hyperplasia, Russian Journal of Biotherapy. 2023; 22: 35.
https://doi.org/10.17650/1726-9784-2023-22-4-35-42 |
| 9 |
2024 |
Sandra C. Ordonez-Rubiano, Brayden P. Strohmier, Surbhi Sood, Emily C. Dykhuizen. SWI/SNF chromatin remodelers in prostate cancer progression, Frontiers in Epigenetics and Epigenomics. 2024; 1: 1337345.
https://doi.org/10.3389/freae.2023.1337345 |
